Today, Petros Pharmaceuticals Inc Inc’s (NASDAQ: PTPI) stock fell $0.03, accounting for a 1.45% decrease. Petros opened at $2.08 before trading between $2.13 and $1.99 throughout Thursday’s session. The activity saw Petros’s market cap fall to $20,046,262 on 30,159 shares -below their 30-day average of 61,037.
About Petros Pharmaceuticals Inc
Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men’s health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men’s health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie’s disease, hormone health and substance use disorders.